Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab and In-Office Nasal Polypectomy in CRS
NCT07814924Phase 4Recruiting
- Sponsor
- IDIVAL
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
A Phase 4 trial of mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by IDIVAL. Started Dec 2024; status: recruiting.
02
Drugs
mepolizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07814924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07814924.